MedTrace Logo

CoVID-19 Evaluation of Neurological and Autonomic Nervous System Troubles in Intensive Care Unit Patients

NCT06060795 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-09-29

No results posted yet for this study

Summary

Since the spread of the COVID-19 disease, several studies have reported the presence of neurological symptoms in patients infected with SARS-CoV-2 such as dysgeusia, hypo or anosmia, hypopsia, the presence of headaches or neuralgia. It has also been described an inconsistent association, in the most severe patients, neurological disorders such as labile arterial hypertension, persistent central fever, vigilance disorders as well as a poor adaptation of the cardio vascular and respiratory systems characterized by paradoxical bradycardia and the frequent absence of polypnea in response to profound hypoxemia. These different functional signs are usually described in particular in patients with impairment of the autonomic nervous system (ANS) in connection with other neuropathological processes.

Conditions

  • Respiratory Symptoms
  • Autonomic Nervous System Dysfunction

Interventions

DIAGNOSTIC_TEST

Electro-conductance measurement

Interventions are done to diagnose Autonomic Nervous system Troubles

Sponsors & Collaborators

  • Centre Hospitalier St Anne

    lead OTHER

Principal Investigators

  • DANIEL Matthieu, MD, PhD · Centre hospitalier Sainte Anne

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-06
Primary Completion
2021-01-13
Completion
2021-01-13

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06060795 on ClinicalTrials.gov